EichorEICHOR
Condition: Safety In Asthma Patients Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Safety In Asthma Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Phase 2 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT06441812Tezspire Cardiac Events PASS
Phase N/A · 4 location(s) · AstraZeneca · NCT06951867A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Wit
Phase 1/Phase 2 · 12 location(s) · Bambusa Therapeutics · NCT07436949Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Ast
Phase 1/Phase 2 · 1 location(s) · University of Zurich · NCT06960382Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06837922Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · 160 location(s) · AstraZeneca · NCT06750289A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Phase 2 · 14 location(s) · Kinaset Therapeutics Inc · NCT07532265Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Phase 2 · 13 location(s) · Oneness Biotech Co., Ltd. · NCT05008965Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
Phase 1 · 3 location(s) · Aspeya, Inc. · NCT07665892Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04435990Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Phase 3 · 19 location(s) · Inmunotek S.L. · NCT07348302Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma
Phase 2 · 1 location(s) · Shanghai Novamab Biopharmaceuticals Co., Ltd. · NCT07589439TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Phase 3 · 101 location(s) · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT06829784Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Phase 3 · 27 location(s) · Inmunotek S.L. · NCT04898283Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inha
Phase 3 · 2 location(s) · Chiesi Farmaceutici S.p.A. · NCT07546981Efficacy and Safety Study of 610 in Patients With Severe Asthma
Phase 3 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT06323213Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT06775340Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Phase 3 · 1 location(s) · Daewon Pharmaceutical Co., Ltd. · NCT07168473Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2 · 1 location(s) · Longbio Pharma · NCT07342803A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07015749
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.